Morepen Laboratories Ltd (MOREPENLAB) News & Corporate Actions | Announcements, Board Meetings, Splits, Bonuses, Rights Issues

{
  "main_header": {
    "sid": 546345,
    "name": "Morepen Labs.",
    "stock_name": "Morepen Labs.",
    "full_name": "Morepen Laboratories Ltd",
    "name_url": "stocks-analysis/morepen-labs",
    "exchange": 0,
    "exchangecode": "",
    "country_id": 34,
    "currency": "INR",
    "cmp": "39.53",
    "chg": 2.81,
    "chgp": "7.65%",
    "dir": 1,
    "prev_price": "36.72",
    "mcapval": "2,081.00 Cr",
    "mcap": "Small Cap",
    "scripcode": 500288,
    "symbol": "MOREPENLAB",
    "ind_name": "Pharmaceuticals & Biotechnology",
    "ind_code": 4,
    "indexname": "",
    "isin": "INE083A01026",
    "curr_date": "Feb 09",
    "curr_time": "",
    "bse_nse_vol": "45.78 lacs",
    "exc_status": "Active",
    "traded_date": "Feb 09, 2026",
    "traded_date_str": "2026 02 09",
    "score": "",
    "scoreText": "",
    "Live": 0,
    "market_time": 0,
    "is_blur": 1,
    "is_blur_class": "blur-register-score-header",
    "is_blur_url": "https://www.marketsmojo.com/mojofeed/register?redirect=/stocks-analysis/morepen-labs-546345-0&utm_source=Spage_Header_Score",
    "mojoone": {
      "ismore": 0,
      "all_data": []
    }
  },
  "news": {
    "results": [
      {
        "title": "Morepen Laboratories Ltd Hits Intraday High with 7.33% Surge on 9 Feb 2026",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/morepen-laboratories-ltd-hits-intraday-high-with-733-surge-on-9-feb-2026-3828744",
        "imagepath": "https://i.marketsmojo.com/newsimg/2026/2/MorepenLaborato_priceRelatedfactors_3828744.png",
        "date": "2026-02-09 11:47:30",
        "description": "Morepen Laboratories Ltd witnessed a robust intraday rally on 9 Feb 2026, surging to an intraday high of Rs 39.43, marking a 7.38% increase from its previous close. This strong performance outpaced the Pharmaceuticals & Biotechnology sector and the broader market indices, reflecting notable trading momentum during the session."
      },
      {
        "title": "Morepen Laboratories Ltd is Rated Strong Sell",
        "link": "https://www.marketsmojo.com/news/stock-recommendation/morepen-laboratories-ltd-is-rated-strong-sell-3828270",
        "imagepath": "https://i.marketsmojo.com/newsimg/2026/2/MorepenLaborato_mojoScore_3828270.png",
        "date": "2026-02-09 10:11:11",
        "description": "Morepen Laboratories Ltd is rated Strong Sell by MarketsMOJO. This rating was last updated on 24 Nov 2025, reflecting a change from the previous 'Sell' grade. However, the analysis and financial metrics discussed here represent the stock's current position as of 09 February 2026, providing investors with the latest insights into the company’s performance and outlook."
      },
      {
        "title": "Morepen Laboratories Ltd Valuation Shifts Signal Price Attractiveness Amid Sector Challenges",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/morepen-laboratories-ltd-valuation-shifts-signal-price-attractiveness-amid-sector-challenges-3827823",
        "imagepath": "https://i.marketsmojo.com/newsimg/2026/2/MorepenLaborato_valuationdot_3827823.png",
        "date": "2026-02-09 08:01:20",
        "description": "Morepen Laboratories Ltd has seen a notable shift in its valuation parameters, moving from a fair to an attractive rating despite ongoing market headwinds and a challenging sector environment. This change reflects a recalibration of price multiples relative to historical averages and peer benchmarks, offering investors a fresh perspective on the stock’s price attractiveness within the Pharmaceuticals & Biotechnology sector."
      },
      {
        "title": "When is the next results date for Morepen Laboratories Ltd?",
        "link": "https://www.marketsmojo.com/news/result-analysis/when-is-the-next-results-date-for-morepen-laboratories-ltd-3821275",
        "imagepath": "",
        "date": "2026-02-04 23:17:35",
        "description": "The next results date for Morepen Laboratories Ltd is scheduled for 10 February 2026...."
      },
      {
        "title": "Morepen Laboratories Ltd Opens with Strong Gap Up Reflecting Positive Market Sentiment",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/morepen-laboratories-ltd-opens-with-strong-gap-up-reflecting-positive-market-sentiment-3817917",
        "imagepath": "https://i.marketsmojo.com/newsimg/2026/2/MorepenLaborato_gapup_3817917.png",
        "date": "2026-02-03 09:55:22",
        "description": "Morepen Laboratories Ltd witnessed a robust start to the trading session on 3 Feb 2026, opening with a significant gap up of 6.57%, reflecting positive market sentiment within the Pharmaceuticals & Biotechnology sector. The stock outperformed its sector peers and broader indices, signalling a strong intraday momentum."
      },
      {
        "title": "Morepen Laboratories Ltd Valuation Shifts to Fair Amidst Market Volatility",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/morepen-laboratories-ltd-valuation-shifts-to-fair-amidst-market-volatility-3813651",
        "imagepath": "https://i.marketsmojo.com/newsimg/2026/2/MorepenLaborato_valuationdot_3813651.png",
        "date": "2026-02-01 08:02:51",
        "description": "Morepen Laboratories Ltd has experienced a notable shift in its valuation parameters, moving from an attractive to a fair rating, reflecting evolving market perceptions and sector dynamics. Despite a recent uptick in share price, the company’s price-to-earnings (P/E) and price-to-book value (P/BV) ratios now align more closely with industry averages, signalling a recalibration of investor expectations amid broader pharmaceutical sector pressures."
      },
      {
        "title": "Morepen Laboratories Ltd is Rated Strong Sell",
        "link": "https://www.marketsmojo.com/news/stock-recommendation/morepen-laboratories-ltd-is-rated-strong-sell-3809039",
        "imagepath": "https://i.marketsmojo.com/newsimg/2026/1/MorepenLaborato_mojoScore_3809039.png",
        "date": "2026-01-29 10:11:07",
        "description": "Morepen Laboratories Ltd is rated Strong Sell by MarketsMOJO, with this rating last updated on 24 Nov 2025. However, the analysis and financial metrics discussed here reflect the company’s current position as of 29 January 2026, providing investors with the latest insights into its performance and outlook."
      },
      {
        "title": "Morepen Laboratories Ltd Stock Hits 52-Week Low Amidst Continued Downtrend",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/morepen-laboratories-ltd-stock-hits-52-week-low-amidst-continued-downtrend-3805633",
        "imagepath": "https://i.marketsmojo.com/newsimg/2026/1/MorepenLaborato_priceRelatedfactors_3805633.png",
        "date": "2026-01-27 10:10:18",
        "description": "Morepen Laboratories Ltd has touched a new 52-week low of Rs.33.48 today, marking a significant decline in its stock price amid continued underperformance relative to its sector and benchmark indices."
      },
      {
        "title": "Morepen Laboratories Ltd Falls to 52-Week Low of Rs.34.1 Amidst Continued Downtrend",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/morepen-laboratories-ltd-falls-to-52-week-low-of-rs341-amidst-continued-downtrend-3802037",
        "imagepath": "https://i.marketsmojo.com/newsimg/2026/1/MorepenLaborato_priceRelatedfactors_3802037.png",
        "date": "2026-01-23 14:14:21",
        "description": "Morepen Laboratories Ltd, a player in the Pharmaceuticals & Biotechnology sector, recorded a new 52-week low of Rs.34.1 today, marking a significant decline in its stock price amid broader market pressures and company-specific performance factors."
      }
    ],
    "total": 369,
    "sid": "546345",
    "stock_news_url": "https://www.marketsmojo.com/news/morepen-laboratories-546345"
  },
  "announcements": [
    {
      "caption": "Board Meeting Intimation for Q3-FY 26 Unaudited Financial Results",
      "datetime": "03-Feb-2026",
      "details": "Morepen Laboratories Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 10/02/2026 inter alia to consider and approve Q3-FY 26 Unaudited Financial Results",
      "source": "BSE"
    },
    {
      "caption": "Report On Transfer Requests Of Physical Shares Re-Lodged Under The Special Window",
      "datetime": "28-Jan-2026",
      "details": "Please find attached the report for the period from 1 January 2026 to 6 January 2026",
      "source": "BSE"
    },
    {
      "caption": "Announcement Under Regulation 30 Of SEBI (LODR) Regulations 2015",
      "datetime": "08-Jan-2026",
      "details": "Please find attached disclosure under Regulation 30 of SEBI (LODR) Regulations 2015",
      "source": "BSE"
    }
  ],
  "corporate_actions": [
    {
      "img": "board-meeting.svg",
      "title": "BOARD MEETING",
      "msg": "",
      "data": [
        {
          "title": "BOARD MEETING",
          "txt": "(10 Feb 2026)"
        }
      ]
    },
    {
      "img": "dividend.svg",
      "title": "DIVIDEND",
      "msg": "",
      "data": [
        {
          "txt": "Morepen Laboratories Ltd has declared <strong>10%</strong> dividend, ex-date: 29 Aug 25",
          "dt": "2025-08-29",
          "middle_text": "Dividend Alert"
        }
      ]
    },
    {
      "img": "splits.svg",
      "title": "SPLITS",
      "msg": "No <strong>Splits</strong> history available",
      "data": []
    },
    {
      "img": "bonus.svg",
      "title": "BONUS",
      "msg": "No <strong>Bonus</strong> history available",
      "data": []
    },
    {
      "img": "rights-issues.svg",
      "title": "RIGHTS",
      "msg": "No <strong>Rights</strong> history available",
      "data": []
    }
  ]
}

News and Views

Morepen Laboratories Ltd Hits Intraday High with 7.33% Surge on 9 Feb 2026

2026-02-09 11:47:30

Morepen Laboratories Ltd witnessed a robust intraday rally on 9 Feb 2026, surging to an intraday high of Rs 39.43, marking a 7.38% increase from its previous close. This strong performance outpaced the Pharmaceuticals & Biotechnology sector and the broader market indices, reflecting notable trading momentum during the session.

Read full news article

Morepen Laboratories Ltd is Rated Strong Sell

2026-02-09 10:11:11

Morepen Laboratories Ltd is rated Strong Sell by MarketsMOJO. This rating was last updated on 24 Nov 2025, reflecting a change from the previous 'Sell' grade. However, the analysis and financial metrics discussed here represent the stock's current position as of 09 February 2026, providing investors with the latest insights into the company’s performance and outlook.

Read full news article

Morepen Laboratories Ltd Valuation Shifts Signal Price Attractiveness Amid Sector Challenges

2026-02-09 08:01:20

Morepen Laboratories Ltd has seen a notable shift in its valuation parameters, moving from a fair to an attractive rating despite ongoing market headwinds and a challenging sector environment. This change reflects a recalibration of price multiples relative to historical averages and peer benchmarks, offering investors a fresh perspective on the stock’s price attractiveness within the Pharmaceuticals & Biotechnology sector.

Read full news article

When is the next results date for Morepen Laboratories Ltd?

2026-02-04 23:17:35

The next results date for Morepen Laboratories Ltd is scheduled for 10 February 2026....

Read full news article

Morepen Laboratories Ltd Opens with Strong Gap Up Reflecting Positive Market Sentiment

2026-02-03 09:55:22

Morepen Laboratories Ltd witnessed a robust start to the trading session on 3 Feb 2026, opening with a significant gap up of 6.57%, reflecting positive market sentiment within the Pharmaceuticals & Biotechnology sector. The stock outperformed its sector peers and broader indices, signalling a strong intraday momentum.

Read full news article

Morepen Laboratories Ltd Valuation Shifts to Fair Amidst Market Volatility

2026-02-01 08:02:51

Morepen Laboratories Ltd has experienced a notable shift in its valuation parameters, moving from an attractive to a fair rating, reflecting evolving market perceptions and sector dynamics. Despite a recent uptick in share price, the company’s price-to-earnings (P/E) and price-to-book value (P/BV) ratios now align more closely with industry averages, signalling a recalibration of investor expectations amid broader pharmaceutical sector pressures.

Read full news article

Morepen Laboratories Ltd is Rated Strong Sell

2026-01-29 10:11:07

Morepen Laboratories Ltd is rated Strong Sell by MarketsMOJO, with this rating last updated on 24 Nov 2025. However, the analysis and financial metrics discussed here reflect the company’s current position as of 29 January 2026, providing investors with the latest insights into its performance and outlook.

Read full news article

Morepen Laboratories Ltd Stock Hits 52-Week Low Amidst Continued Downtrend

2026-01-27 10:10:18

Morepen Laboratories Ltd has touched a new 52-week low of Rs.33.48 today, marking a significant decline in its stock price amid continued underperformance relative to its sector and benchmark indices.

Read full news article

Morepen Laboratories Ltd Falls to 52-Week Low of Rs.34.1 Amidst Continued Downtrend

2026-01-23 14:14:21

Morepen Laboratories Ltd, a player in the Pharmaceuticals & Biotechnology sector, recorded a new 52-week low of Rs.34.1 today, marking a significant decline in its stock price amid broader market pressures and company-specific performance factors.

Read full news article

View All News